
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue
Oncology Today with Dr Neil Love
00:00
The Primary Maintenance Issue in Ovarian Cancer
The only debate in my mind is should you add BAB to that, like the Powell One Regiment. So if I have a patient who's on BAB and I find their Braca positive, I continue to laparip. Single agent, parpen inhibitor maintenance, absolutely 100%, is the standard of care.
Transcript
Play full episode